Adult Vaccines Market - Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2022 - 2028

Adult Vaccines Market - Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2022 - 2028

Vaccination and immunization is aids in prevention of diseases among adults and children. Vaccines are biological suspensions that contain an agent that resembles the disease causing microorganisms and are often made from inactivated microbes, toxins or surface proteins. The active agents present in the vaccine stimulates body’s immune system to recognize the disease causing agent as 'foreign substance' and develop antibodies against it. Vaccines are a preferable and highly recommended preventive measure against certain severe diseases, however, have mild side effects.
Market Dynamics
Development of vaccines for various new diseases and rising awareness regarding advantages of preventive medication are the two prominent factors supporting growth of the market. For instance, according to the Centers for Disease Control and Prevention, 2015, flu vaccinations prevented around 1.9 million flu illnesses, 966,000 flu-associated medical visits, and around 67,000 flu-associated hospitalizations, representing 6.5% lowering of disease burden. However, high complexity in cost of manufacturing a vaccine is one of the major factors negatively affecting growth of the market.
Key features of the study:

This report provides in-depth analysis of adult vaccines market and provides market size (US$ Million) and Cumulative Annual Growth Rate (CAGR %) for the forecast period (2022-2028), considering 2021 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrix for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends,  regional outlook, and competitive strategy adopted by the leading players
It profiles leading players in the global adult vaccines market based on the following parameters – company overview, financial performance, product portfolio, market presence, distribution strategies, key developments and strategies, and future plans
Key companies covered as a part of this study includes GlaxoSmithKline Plc, Merck & Co., Sanofi Pasteur, Pfizer, Inc., CSL Limited, Johnson & Johnson, Serum Institute of India, Medimmune, and AstraZeneca Plc.
Insights from this report would allow marketers and the management authorities of the companies to make informed decision regarding their future product launch, technology up-gradation, market expansion, and marketing tactics
The global adult vaccines market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through the various strategy matrices used in analyzing the adult vaccines market

Detailed Segmentation:

Global Adult Vaccines Market, By Vaccine:

Influenza
Tetanus, Diphtheria, Pertussis (Td/Tdap)
Varicella
Human Papillomavirus
Zoster
Measles, Mumps, Rubella (MMR)
Pneumococcal
Hepatitis
Others

Global Adult Vaccines Market, By Vaccine Type:

Monovalent
Multivalent

Global Adult Vaccines Market, By Technology:

Live Attenuated Vaccines
Inactivated Viral/Bacterial Vaccines
Toxoid Vaccines
Recombinant Vaccines
Conjugate Vaccines

Global Adult Vaccines Market, By Geography:

North America

By Vaccine:

Influenza
Tetanus, Diphtheria, Pertussis (Td/Tdap)
Varicella
Human Papillomavirus
Zoster
Measles, Mumps, Rubella (MMR)
Pneumococcal
Hepatitis
Others

By Vaccine Type:

Monovalent
Multivalent

By Technology:

Live Attenuated Vaccines
Inactivated Viral/Bacterial Vaccines
Toxoid Vaccines
Recombinant Vaccines
Conjugate Vaccines

By Country:

U.S.
Canada

Latin America

By Vaccine:

Influenza
Tetanus, Diphtheria, Pertussis (Td/Tdap)
Varicella
Human Papillomavirus
Zoster
Measles, Mumps, Rubella (MMR)
Pneumococcal
Hepatitis
Others

By Vaccine Type:

Monovalent
Multivalent

By Technology:

Live Attenuated Vaccines
Inactivated Viral/Bacterial Vaccines
Toxoid Vaccines
Recombinant Vaccines
Conjugate Vaccines

By Country:

Brazil
Mexico
Argentina
Rest of Latin America

Europe

By Vaccine:

Influenza
Tetanus, Diphtheria, Pertussis (Td/Tdap)
Varicella
Human Papillomavirus
Zoster
Measles, Mumps, Rubella (MMR)
Pneumococcal
Hepatitis
Others

By Vaccine Type:

Monovalent
Multivalent

By Technology:

Live Attenuated Vaccines
Inactivated Viral/Bacterial Vaccines
Toxoid Vaccines
Recombinant Vaccines
Conjugate Vaccines

By Country:

Germany
U.K.
France
Italy
Spain
Russia
Rest of Europe

Asia Pacific

By Vaccine:

Influenza
Tetanus, Diphtheria, Pertussis (Td/Tdap)
Varicella
Human Papillomavirus
Zoster
Measles, Mumps, Rubella (MMR)
Pneumococcal
Hepatitis
Others

By Vaccine Type:

Monovalent
Multivalent

By Technology:

Live Attenuated Vaccines
Inactivated Viral/Bacterial Vaccines
Toxoid Vaccines
Recombinant Vaccines
Conjugate Vaccines

By Country:

China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific

Middle East

By Vaccine:

Influenza
Tetanus, Diphtheria, Pertussis (Td/Tdap)
Varicella
Human Papillomavirus
Zoster
Measles, Mumps, Rubella (MMR)
Pneumococcal
Hepatitis
Others

By Vaccine Type:

Monovalent
Multivalent

By Technology:

Live Attenuated Vaccines
Inactivated Viral/Bacterial Vaccines
Toxoid Vaccines
Recombinant Vaccines
Conjugate Vaccines

By Country:

GCC
Israel
Rest of Middle East

Africa

By Vaccine:

Influenza
Tetanus, Diphtheria, Pertussis (Td/Tdap)
Varicella
Human Papillomavirus
Zoster
Measles, Mumps, Rubella (MMR)
Pneumococcal
Hepatitis
Others

By Vaccine Type:

Monovalent
Multivalent

By Technology:

Live Attenuated Vaccines
Inactivated Viral/Bacterial Vaccines
Toxoid Vaccines
Recombinant Vaccines
Conjugate Vaccines

By Country:

South Africa
Central Africa
North Africa

Company Profiles

GlaxoSmithKline Plc *

Company Overview
Product Portfolio
Key Highlights
Financial Performance
Strategies

Merck & Co., Inc.
Sanofi Pasteur
Pfizer, Inc.
CSL Limited
Johnson & Johnson
Serum Institute of India
Medimmune
AstraZeneca Plc

“*” marked represents similar segmentation in other categories in the respective section.